Clinical Trial Update: QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead

View source ↗

Summary

The QUARTO-II trial evaluating resynchronization therapy with the Quartet LV quadripolar lead in heart failure patients has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Status: COMPLETED | Results posted: 2018-03-01